| __timestamp | Bristol-Myers Squibb Company | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 12402000000 |
| Thursday, January 1, 2015 | 5920000000 | 17449000000 |
| Friday, January 1, 2016 | 4940000000 | 17834000000 |
| Sunday, January 1, 2017 | 6411000000 | 19551000000 |
| Monday, January 1, 2018 | 6345000000 | 18265000000 |
| Tuesday, January 1, 2019 | 6148000000 | 15607000000 |
| Wednesday, January 1, 2020 | 11143000000 | 15410000000 |
| Friday, January 1, 2021 | 10195000000 | 16541000000 |
| Saturday, January 1, 2022 | 9509000000 | 17482000000 |
| Sunday, January 1, 2023 | 9299000000 | 19381000000 |
| Monday, January 1, 2024 | 11159000000 | 22873000000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Bristol-Myers Squibb and Dr. Reddy's Laboratories have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, Bristol-Myers Squibb's R&D expenses grew by approximately 105%, peaking in 2020 with a significant surge. Meanwhile, Dr. Reddy's Laboratories consistently outpaced its counterpart, with R&D spending increasing by about 56% over the same period, reaching its highest in 2023. This trend highlights Dr. Reddy's sustained focus on innovation, despite Bristol-Myers Squibb's notable spikes. The data reveals a fascinating narrative of strategic priorities, with Dr. Reddy's maintaining a steady upward trajectory, while Bristol-Myers Squibb exhibits more volatility. As we look to the future, these investment patterns may shape the competitive dynamics in the pharmaceutical industry.
R&D Spending Showdown: Eli Lilly and Company vs Dr. Reddy's Laboratories Limited
Analyzing R&D Budgets: Novo Nordisk A/S vs Dr. Reddy's Laboratories Limited
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Bristol-Myers Squibb Company or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and ACADIA Pharmaceuticals Inc.
R&D Insights: How Genmab A/S and Dr. Reddy's Laboratories Limited Allocate Funds
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and Madrigal Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited or Grifols, S.A.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Viking Therapeutics, Inc.
Comparing Innovation Spending: Dr. Reddy's Laboratories Limited and Rhythm Pharmaceuticals, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Mesoblast Limited
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Evotec SE